Clinical Trials Browser

Phase 2 × Adenoma, Islet Cell × lutetium Lu 177 dotatate × Clear all

NCT05247905 2025-04-02

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors

Phase 2 Active not recruiting

Adenoma, Islet Cell